Brighton Jones LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Brighton Jones LLC's IBB Position: Q2 2026 in Review
Brighton Jones LLC reduced its iShares Biotechnology ETF (IBB) stake by 2% in Q2 2026, selling an estimated $8.94K and leaving 2,491 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #816.
Brighton Jones LLC first reported a position in IBB in Q3 2013 and has held it in 16 quarters since. The position peaked at $772K in Q3 2017. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Brighton Jones LLC held 2,491 shares of iShares Biotechnology ETF worth $474K as of Q2 2026.
- Brighton Jones LLC sold 52 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.94K.
- iShares Biotechnology ETF made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #816 holding.
- Brighton Jones LLC first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 16 quarters since.
- Brighton Jones LLC's iShares Biotechnology ETF position peaked at $772K in Q3 2017.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.